help button home button Am J Pathol ASIP WHAT IS IT?
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rand, M. L.
Right arrow Articles by Ringler, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rand, M. L.
Right arrow Articles by Ringler, D. J.

American Journal of Pathology, Vol 148, 855-864, Copyright © 1996 by American Society for Investigative Pathology


REGULAR ARTICLES

Inhibition of T cell recruitment and cutaneous delayed-type hypersensitivity-induced inflammation with antibodies to monocyte chemoattractant protein-1

ML Rand, JS Warren, MK Mansour, W Newman and DJ Ringler
Experimental Therapeutics Group, LeukoSite Inc., Cambridge, Massachusetts 02142, USA.

Leukocytes express chemokine receptors that, upon ligand recognition, are believed to activate and induce the directed migration of these cells from the vasculature to sites of tissue injury. Previous investigations of human and animal inflammatory tissue have revealed that expression of chemokines can be increased in association with leukocyte infiltration. Monocyte chemotactic protein-1 (MCP-1) mediates monocyte chemotaxis in vitro and migration of monocytes to inflammatory sites in vivo. More recently T cell chemotaxis to MCP-1 has been observed in vitro, but the contribution of this protein to T cell migration in vivo and to lymphocyte-mediated inflammation has not been determined. In this report, we show that using a rat model of cutaneous delayed hypersensitivity, MCP-1 expression correlates spatially and kinetically with T cell and monocyte recruitment and that antibodies directed to MCP-1 when administered therapeutically to animals undergoing delayed hypersensitivity can almost completely abolish T cell migration and inflammatory sequelae. Moreover the concentration of antibody needed to inhibit T cell trafficking to inflammatory sites is almost on order of magnitude lower than that needed to impede monocyte recruitment. Therefore, MCP-1 is functionally relevant in the genesis of delayed hypersensitivity and may be a useful therapeutic target for diseases mediated in part by T lymphocytes.


This article has been cited by other articles:


Home page
J BiochemHome page
K. Yoshinaga, M. Matsumoto, M. Torikai, K. Sugyo, S. Kuroki, K. Nogami, R. Matsumoto, S. Hashiguchi, Y. Ito, T. Nakashima, et al.
Ig L-chain Shuffling for Affinity Maturation of Phage Library-derived Human Anti-human MCP-1 Antibody Blocking its Chemotactic Activity
J. Biochem., May 1, 2008; 143(5): 593 - 601.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. U. Norman, S. Hulliger, P. Colarusso, and P. Kubes
Multichannel Fluorescence Spinning Disk Microscopy Reveals Early Endogenous CD4 T Cell Recruitment in Contact Sensitivity via Complement
J. Immunol., January 1, 2008; 180(1): 510 - 521.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Yoshimura and M. Takahashi
IFN-{gamma}-Mediated Survival Enables Human Neutrophils to Produce MCP-1/CCL2 in Response to Activation by TLR Ligands
J. Immunol., August 1, 2007; 179(3): 1942 - 1949.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
A. Nambu, S. Nakae, and Y. Iwakura
IL-1{beta}, but not IL-1{alpha}, is required for antigen-specific T cell activation and the induction of local inflammation in the delayed-type hypersensitivity responses
Int. Immunol., May 1, 2006; 18(5): 701 - 712.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Takanami-Ohnishi, S. Amano, S. Kimura, S. Asada, A. Utani, M. Maruyama, H. Osada, H. Tsunoda, Y. Irukayama-Tomobe, K. Goto, et al.
Essential Role of p38 Mitogen-activated Protein Kinase in Contact Hypersensitivity
J. Biol. Chem., September 27, 2002; 277(40): 37896 - 37903.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. R. Traynor, A. C. Herring, M. E. Dorf, W. A. Kuziel, G. B. Toews, and G. B. Huffnagle
Differential Roles of CC Chemokine Ligand 2/Monocyte Chemotactic Protein-1 and CCR2 in the Development of T1 Immunity
J. Immunol., May 1, 2002; 168(9): 4659 - 4666.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Akiba, J. Kehren, M.-T. Ducluzeau, M. Krasteva, F. Horand, D. Kaiserlian, F. Kaneko, and J.-F. Nicolas
Skin Inflammation During Contact Hypersensitivity Is Mediated by Early Recruitment of CD8+ T Cytotoxic 1 Cells Inducing Keratinocyte Apoptosis
J. Immunol., March 15, 2002; 168(6): 3079 - 3087.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. Yamashiro, H. Kamohara, J.-M. Wang, D. Yang, W.-H. Gong, and T. Yoshimura
Phenotypic and functional change of cytokine-activated neutrophils: inflammatory neutrophils are heterogeneous and enhance adaptive immune responses
J. Leukoc. Biol., May 1, 2001; 69(5): 698 - 704.
[Abstract] [Full Text]


Home page
BloodHome page
M. Goebeler, R. Gillitzer, K. Kilian, K. Utzel, E.-B. Brocker, U. R. Rapp, and S. Ludwig
Multiple signaling pathways regulate NF-{kappa}B-dependent transcription of the monocyte chemoattractant protein-1 gene in primary endothelial cells
Blood, January 1, 2001; 97(1): 46 - 55.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Yamashiro, J.-M. Wang, D. Yang, W.-H. Gong, H. Kamohara, and T. Yoshimura
Expression of CCR6 and CD83 by cytokine-activated human neutrophils
Blood, December 1, 2000; 96(12): 3958 - 3963.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. R. Kitching, P. G. Tipping, M. Kurimoto, and S. R. Holdsworth
IL-18 Has IL-12-Independent Effects in Delayed-Type Hypersensitivity: Studies in Cell-Mediated Crescentic Glomerulonephritis
J. Immunol., October 15, 2000; 165(8): 4649 - 4657.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Mori, A. Ueda, S. Ikeda, Y. Yamasaki, Y. Yamada, M. Tomonaga, S. Morikawa, R. Geleziunas, T. Yoshimura, and N. Yamamoto
Human T-Cell Leukemia Virus Type I Tax Activates Transcription of the Human Monocyte Chemoattractant Protein-1 Gene through Two Nuclear Factor-{{kappa}}B Sites
Cancer Res., September 1, 2000; 60(17): 4939 - 4945.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
T. Sugiura, Y. Kawaguchi, M. Harigai, K. Takagi, S. Ohta, C. Fukasawa, M. Hara, and N. Kamatani
Increased CD40 Expression on Muscle Cells of Polymyositis and Dermatomyositis: Role of CD40-CD40 Ligand Interaction in IL-6, IL-8, IL-15, and Monocyte Chemoattractant Protein-1 Production
J. Immunol., June 15, 2000; 164(12): 6593 - 6600.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Yoshimoto, C.-R. Wang, T. Yoneto, A. Matsuzawa, W. W. Cruikshank, and H. Nariuchi
Role of IL-16 in delayed-type hypersensitivity reaction
Blood, May 1, 2000; 95(9): 2869 - 2874.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. A. Doyle and J. W. Murphy
Role of the C-C Chemokine, TCA3, in the Protective Anticryptococcal Cell-Mediated Immune Response
J. Immunol., April 15, 1999; 162(8): 4824 - 4833.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. P. Perera, C. K. Goldman, and T. A. Waldmann
IL-15 Induces the Expression of Chemokines and Their Receptors in T Lymphocytes
J. Immunol., March 1, 1999; 162(5): 2606 - 2612.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Goebeler, K. Kilian, R. Gillitzer, M. Kunz, T. Yoshimura, E.-B. Brocker, U. R. Rapp, and S. Ludwig
The MKK6/p38 Stress Kinase Cascade Is Critical for Tumor Necrosis Factor-alpha -Induced Expression of Monocyte-Chemoattractant Protein-1 in Endothelial Cells
Blood, February 1, 1999; 93(3): 857 - 865.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Albanesi, A. Cavani, and G. Girolomoni
IL-17 Is Produced by Nickel-Specific T Lymphocytes and Regulates ICAM-1 Expression and Chemokine Production in Human Keratinocytes: Synergistic or Antagonist Effects with IFN-{gamma} and TNF-{alpha}
J. Immunol., January 1, 1999; 162(1): 494 - 502.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. M. Hogaboam, N. W. Lukacs, S. W. Chensue, R. M. Strieter, and S. L. Kunkel
Monocyte Chemoattractant Protein-1 Synthesis by Murine Lung Fibroblasts Modulates CD4+ T Cell Activation
J. Immunol., May 1, 1998; 160(9): 4606 - 4614.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
W. A. Kuziel, S. J. Morgan, T. C. Dawson, S. Griffin, O. Smithies, K. Ley, and N. Maeda
Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2
PNAS, October 28, 1997; 94(22): 12053 - 12058.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
L. Wu, W. A. Paxton, N. Kassam, N. Ruffing, J. B. Rottman, N. Sullivan, H. Choe, J. Sodroski, W. Newman, R. A. Koup, et al.
CCR5 Levels and Expression Pattern Correlate with Infectability by Macrophage-tropic HIV-1, In Vitro
J. Exp. Med., May 5, 1997; 185(9): 1681 - 1692.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Mirzadegan, F. Diehl, B. Ebi, S. Bhakta, I. Polsky, D. McCarley, M. Mulkins, G. S. Weatherhead, J.-M. Lapierre, J. Dankwardt, et al.
Identification of the Binding Site for a Novel Class of CCR2b Chemokine Receptor Antagonists. BINDING TO A COMMON CHEMOKINE RECEPTOR MOTIF WITHIN THE HELICAL BUNDLE
J. Biol. Chem., August 11, 2000; 275(33): 25562 - 25571.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
A. Turler, N. T. Schwarz, E. Turler, J. C. Kalff, and A. J. Bauer
MCP-1 causes leukocyte recruitment and subsequently endotoxemic ileus in rat
Am J Physiol Gastrointest Liver Physiol, January 1, 2002; 282(1): G145 - G155.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the American Society for Investigative Pathology.